Not recognized by the capital markets? Guangxi Liuyao Group: The company's stock price does not match its value | Direct coverage of the earnings conference.

1. At the earnings conference, the chairman of guangxi liuyao group, Zhu Chaoyang, stated that the company's market cap, stock price, and company value are not aligned; 2. The company secretary Xu Yang stated that the company will improve the issue of high accounts receivable through measures such as strengthening the assessment of collection indicators for business personnel; 3. Xu Yang introduced the progress of the company's AI application business in response to investors' concerns.

cls.cnDec 9 07:31 ET

How do domestic semiconductors industry chain grow against the wind? At this closed-door event, many "little giant" companies shared their insights and advice.

① The release of a new round of export control entity lists has fostered the consensus within the industry to cultivate and develop a domestic supply chain system. ② Several emerging companies in the semiconductors field recently stated at an industry event that the domestic market for semiconductor equipment and memory chips is vast, and small and medium-sized enterprises possess the resilience for growth and development.

cls.cnDec 5 21:39 ET

henan lingrui pharmaceutical plans to acquire Silver Valley Pharmaceuticals for 0.782 billion. Traditional Chinese medicine patch and plaster leading the cross-border pharmaceutical market | Quick reading announcement

①Henan Lingrui Pharmaceutical intends to acquire all the equity of Silver Valley Pharmaceutical for 0.782 billion yuan, entering the market of innovative drugs in chemical medicine. ②According to Mononucleosis Medical Data, Silver Valley Pharmaceutical's sales in 2023 exceeded 0.4 billion yuan, with the top-selling product being Jin'erli, accounting for about 70% of the company's total revenue, and the growth rate of Class 1 new drug Biti Cong quickly. ③If the acquisition of Silver Valley Pharmaceutical proceeds smoothly, the company's previously set stock-based incentive unlocking target may be difficult to achieve or significantly reduced.

cls.cnDec 4 10:07 ET

Intense competition in CRO has reduced gross margin. Sunlight Nuohe is entering the animal health field to seek new growth points.

① Sunshine Nuohuo has experienced growth in revenue and net income in the first three quarters of this year compared to previous years, but intense competition in the industry has led to a decline in gross margin, and the chairman revealed that the company is increasing its investment in research and development. ② To seek new growth points, Sunshine Nuohuo is expanding its CRO business from the human pharmaceutical field to the animal health field by establishing subsidiaries, and has signed service orders with several medium and large animal pharmaceutical companies.

cls.cnDec 2 02:59 ET

The first A-share company to complete a repurchase using special loans! This week, deppon logistics and 14 other stocks disclosed repurchase and shareholding refinancing plans. Here is a list of the relevant A-share companies.

① Recently, A-share companies that have obtained repurchase and shareholding loan support continue to expand. According to incomplete statistics from Caixin, this week 14 A-share listed companies have announced the disclosure of repurchase and shareholding refinancing situations (see table); ② Deppon Logistics plans to increase its shareholding by 0.3 billion yuan to -0.6 billion yuan and the loan amount will not exceed 0.4 billion yuan. Fushun Special Steel is the first A-share company to disclose the use of own funds and repurchase special loans to complete the repurchase.

cls.cnNov 30 02:21 ET

Henan Lingrui Pharmaceutical discloses a stock-based incentive plan Unveiling conditions: average annual double-digit growth in non-GAAP net income | Speed ​​reading announcement

①Henan Lingrui Pharmaceutical has announced a new round of restricted stock incentive plan and employee stock ownership plan, slightly lowering the assessment target compared to the previous incentive plan, but still maintaining a double-digit non-GAAP performance assessment requirement. ②In addition to Henan Lingrui Pharmaceutical, tibet cheezheng tibetan medicine has also previously announced an employee stock ownership plan with higher assessment targets, and the industry expects bone health to be a high-potential category in the out-of-hospital market.

cls.cnNov 29 10:25 ET